These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19786462)

  • 21. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected.
    Gómez JM; Maravall FJ; Gómez N; Navarro MA; Casamitjana R; Soler J
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):213-9. PubMed ID: 12580938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
    Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
    Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women.
    Vadgama JV; Wu Y; Datta G; Khan H; Chillar R
    Oncology; 1999 Nov; 57(4):330-40. PubMed ID: 10575321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
    Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
    Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
    Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.
    Gallagher EJ; Fei K; Feldman SM; Port E; Friedman NB; Boolbol SK; Killelea B; Pilewskie M; Choi L; King T; Nayak A; Franco R; Cruz D; Antoniou IM; LeRoith D; Bickell NA
    Breast Cancer Res; 2020 May; 22(1):40. PubMed ID: 32393319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.
    Verheus M; Maskarinec G; Woolcott CG; Haiman CA; Le Marchand L; Henderson BE; Cheng I; Kolonel LN
    Int J Cancer; 2010 Sep; 127(5):1115-23. PubMed ID: 20039319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body shape throughout life and correlations with IGFs and GH.
    Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.
    Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A;
    Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
    Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
    Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.
    Rice MS; Tworoger SS; Rosner BA; Pollak MN; Hankinson SE; Tamimi RM
    Breast Cancer Res Treat; 2012 Dec; 136(3):805-12. PubMed ID: 23085768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case-control study of body mass index and breast cancer risk in white and African-American women.
    Berstad P; Coates RJ; Bernstein L; Folger SG; Malone KE; Marchbanks PA; Weiss LK; Liff JM; McDonald JA; Strom BL; Simon MS; Deapen D; Press MF; Burkman RT; Spirtas R; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1532-44. PubMed ID: 20501755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women.
    McCormack VA; Dowsett M; Folkerd E; Johnson N; Palles C; Coupland B; Holly JM; Vinnicombe SJ; Perry NM; dos Santos Silva I
    Breast Cancer Res; 2009; 11(3):R38. PubMed ID: 19545414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.